Oncology, Immunology, Inflammation, Neurology

Affilogic is a private biotech company specialized in discovering and developing affinity proteins Nanofitins through early-stage collaborations. Nanofitin-based biotherapeutics are currently developed in collaboration with Sanofi, Takeda Pharmaceuticals, Samabriva, and other undisclosed pharma companies.

Each Nanofitin is 20 times smaller than an antibody and hyper stable. Nanofitins are easily combined with third-party molecules or with each other by simple, rapid and proven methods to design an ideal targeted molecule. Nanofitins can be designed as targeted inhibitors, or as vectors for specific transport: Nanofitin-Drug Conjugates, Conjugation to Antibodies, Multispecific Nanofitins, Imaging.

We are looking for new partners for custom generation of Nanofitins as next-generation biopharmaceuticals.